Literature DB >> 28652311

A Nutrient-Regulated Cyclic Diguanylate Phosphodiesterase Controls Clostridium difficile Biofilm and Toxin Production during Stationary Phase.

Erin B Purcell1, Robert W McKee2, David S Courson1, Elizabeth M Garrett2, Shonna M McBride3, Richard E Cheney4, Rita Tamayo5.   

Abstract

The signaling molecule cyclic diguanylate (c-di-GMP) mediates physiological adaptation to extracellular stimuli in a wide range of bacteria. The complex metabolic pathways governing c-di-GMP synthesis and degradation are highly regulated, but the specific cues that impact c-di-GMP signaling are largely unknown. In the intestinal pathogen Clostridium difficile, c-di-GMP inhibits flagellar motility and toxin production and promotes pilus-dependent biofilm formation, but no specific biological functions have been ascribed to any of the individual c-di-GMP synthases or phosphodiesterases (PDEs). Here, we report the functional and biochemical characterization of a c-di-GMP PDE, PdcA, 1 of 37 confirmed or putative c-di-GMP metabolism proteins in C. difficile 630. Our studies reveal that pdcA transcription is controlled by the nutrient-regulated transcriptional regulator CodY and accordingly increases during stationary phase. In addition, PdcA PDE activity is allosterically regulated by GTP, further linking c-di-GMP levels to nutrient availability. Mutation of pdcA increased biofilm formation and reduced toxin biosynthesis without affecting swimming motility or global intracellular c-di-GMP. Analysis of the transcriptional response to pdcA mutation indicates that PdcA-dependent phenotypes manifest during stationary phase, consistent with regulation by CodY. These results demonstrate that inactivation of this single PDE gene is sufficient to impact multiple c-di-GMP-dependent phenotypes, including the production of major virulence factors, and suggest a link between c-di-GMP signaling and nutrient availability.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  CodY; biofilm; c-di-GMP; cyclic diguanylate; flagella; flagellar motility; nutrient; toxin

Mesh:

Substances:

Year:  2017        PMID: 28652311      PMCID: PMC5563577          DOI: 10.1128/IAI.00347-17

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  105 in total

Review 1.  Rho and Rac take center stage.

Authors:  Keith Burridge; Krister Wennerberg
Journal:  Cell       Date:  2004-01-23       Impact factor: 41.582

2.  Integration of metabolism and virulence by Clostridium difficile CodY.

Authors:  Sean S Dineen; Shonna M McBride; Abraham L Sonenshein
Journal:  J Bacteriol       Date:  2010-08-13       Impact factor: 3.490

3.  Second-generation recombination-based in vivo expression technology for large-scale screening for Vibrio cholerae genes induced during infection of the mouse small intestine.

Authors:  C G Osorio; J A Crawford; J Michalski; H Martinez-Wilson; J B Kaper; A Camilli
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

4.  Structural basis of activity and allosteric control of diguanylate cyclase.

Authors:  Carmen Chan; Ralf Paul; Dietrich Samoray; Nicolas C Amiot; Bernd Giese; Urs Jenal; Tilman Schirmer
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-29       Impact factor: 11.205

5.  CodY of Streptococcus pneumoniae: link between nutritional gene regulation and colonization.

Authors:  Wouter T Hendriksen; Hester J Bootsma; Silvia Estevão; Theo Hoogenboezem; Anne de Jong; Ronald de Groot; Oscar P Kuipers; Peter W M Hermans
Journal:  J Bacteriol       Date:  2007-11-16       Impact factor: 3.490

6.  Structure of BeF3- -modified response regulator PleD: implications for diguanylate cyclase activation, catalysis, and feedback inhibition.

Authors:  Paul Wassmann; Carmen Chan; Ralf Paul; Andreas Beck; Heiko Heerklotz; Urs Jenal; Tilman Schirmer
Journal:  Structure       Date:  2007-08       Impact factor: 5.006

7.  The second messenger cyclic Di-GMP regulates Clostridium difficile toxin production by controlling expression of sigD.

Authors:  Robert W McKee; Mihnea R Mangalea; Erin B Purcell; Erin K Borchardt; Rita Tamayo
Journal:  J Bacteriol       Date:  2013-09-13       Impact factor: 3.490

8.  Cyclic diguanylate inversely regulates motility and aggregation in Clostridium difficile.

Authors:  Erin B Purcell; Robert W McKee; Shonna M McBride; Christopher M Waters; Rita Tamayo
Journal:  J Bacteriol       Date:  2012-04-20       Impact factor: 3.490

9.  Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile.

Authors:  Charlie G Buffie; Vanni Bucci; Richard R Stein; Peter T McKenney; Lilan Ling; Asia Gobourne; Daniel No; Hui Liu; Melissa Kinnebrew; Agnes Viale; Eric Littmann; Marcel R M van den Brink; Robert R Jenq; Ying Taur; Chris Sander; Justin R Cross; Nora C Toussaint; Joao B Xavier; Eric G Pamer
Journal:  Nature       Date:  2014-10-22       Impact factor: 49.962

10.  Remodeling the zonula adherens in response to tension and the role of afadin in this response.

Authors:  Wangsun Choi; Bipul R Acharya; Grégoire Peyret; Marc-Antoine Fardin; René-Marc Mège; Benoit Ladoux; Alpha S Yap; Alan S Fanning; Mark Peifer
Journal:  J Cell Biol       Date:  2016-04-25       Impact factor: 10.539

View more
  24 in total

1.  CodY-Mediated c-di-GMP-Dependent Inhibition of Mammalian Cell Invasion in Listeria monocytogenes.

Authors:  Ahmed M Elbakush; Kurt W Miller; Mark Gomelsky
Journal:  J Bacteriol       Date:  2018-02-07       Impact factor: 3.490

Review 2.  Regulation of Clostridioides difficile toxin production.

Authors:  Aritri Majumdar; Revathi Govind
Journal:  Curr Opin Microbiol       Date:  2021-11-12       Impact factor: 7.934

3.  Characterization of an operon required for growth on cellobiose in Clostridioides difficile.

Authors:  Md Kamrul Hasan; Babita Adhikari Dhungel; Revathi Govind
Journal:  Microbiology (Reading)       Date:  2021-08       Impact factor: 2.956

4.  Coordinated modulation of multiple processes through phase variation of a c-di-GMP phosphodiesterase in Clostridioides difficile.

Authors:  Leila M Reyes Ruiz; Kathleen A King; Christian Agosto-Burgos; Isabella S Gamez; Nicole C Gadda; Elizabeth M Garrett; Rita Tamayo
Journal:  PLoS Pathog       Date:  2022-07-05       Impact factor: 7.464

5.  Mucin-Degrading Microbes Release Monosaccharides That Chemoattract Clostridioides difficile and Facilitate Colonization of the Human Intestinal Mucus Layer.

Authors:  Melinda A Engevik; Amy C Engevik; Kristen A Engevik; Jennifer M Auchtung; Alexandra L Chang-Graham; Wenly Ruan; Ruth Ann Luna; Joseph M Hyser; Jennifer K Spinler; James Versalovic
Journal:  ACS Infect Dis       Date:  2020-11-11       Impact factor: 5.084

6.  Single cell analysis of nutrient regulation of Clostridioides (Clostridium) difficile motility.

Authors:  David S Courson; Astha Pokhrel; Cody Scott; Melissa Madrill; Alden J Rinehold; Rita Tamayo; Richard E Cheney; Erin B Purcell
Journal:  Anaerobe       Date:  2019-08-03       Impact factor: 3.331

7.  Phase-variable expression of pdcB, a phosphodiesterase, influences sporulation in Clostridioides difficile.

Authors:  Babita Adhikari Dhungel; Revathi Govind
Journal:  Mol Microbiol       Date:  2021-10-18       Impact factor: 3.501

8.  Pleiotropic roles of Clostridium difficile sin locus.

Authors:  Brintha Parasumanna Girinathan; Junjun Ou; Bruno Dupuy; Revathi Govind
Journal:  PLoS Pathog       Date:  2018-03-12       Impact factor: 6.823

9.  Cyclic Diguanylate Regulates Virulence Factor Genes via Multiple Riboswitches in Clostridium difficile.

Authors:  Robert W McKee; Carissa K Harvest; Rita Tamayo
Journal:  mSphere       Date:  2018-10-24       Impact factor: 4.389

10.  Clostridium difficile Biofilm: Remodeling Metabolism and Cell Surface to Build a Sparse and Heterogeneously Aggregated Architecture.

Authors:  Isabelle Poquet; Laure Saujet; Alexis Canette; Marc Monot; Jovanna Mihajlovic; Jean-Marc Ghigo; Olga Soutourina; Romain Briandet; Isabelle Martin-Verstraete; Bruno Dupuy
Journal:  Front Microbiol       Date:  2018-09-12       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.